{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:46:36Z","timestamp":1786124796042,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T00:00:00Z","timestamp":1519257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NEUROSURGERY","NEUROS"],"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>The available literature to guide treatment decision making in esthesioneuroblastoma (ENB) is limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To define treatment patterns and outcomes in ENB according to treatment modality using a large national cancer registry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>This study is a retrospective cohort analysis of 931 patients with a diagnosis of ENB who were treated with surgery, radiation therapy, and\/or chemotherapy in the United States between the years of 2004 and 2012. Log-rank statistics were used to compare overall survival by primary treatment modality. Logistic regression modeling was used to identify predictors of receipt of postoperative radiotherapy (PORT). Cox proportional hazards modeling was used to determine the survival benefit of PORT. Subgroup analyses identified subgroups that derived the greatest benefit of PORT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>\n                      Primary surgery was the most common treatment modality (90%) and resulted in superior survival compared to radiation (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .01) or chemotherapy (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .01). On multivariate analysis, PORT was associated with decreased risk of death (hazard ratio [HR] 0.53,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .01). PORT showed a survival benefit in Kadish stage C (HR 0.42,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .01) and D (HR 0.09,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .01), but not Kadish A (HR 1.17,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .74) and B (HR 1.37,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .80). Patients who received chemotherapy derived greater benefit from PORT (HR 0.22,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .01) compared with those who did not (HR 0.68,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .13). Predictors of PORT included stage, grade, extent of resection, and chemotherapy use.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Best outcomes were obtained in patients undergoing primary surgery. The benefit of PORT was driven by patients with stages C and D disease, and by those also receiving chemotherapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuros\/nyx535","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T15:11:30Z","timestamp":1509117090000},"page":"940-947","source":"Crossref","is-referenced-by-count":26,"title":["Esthesioneuroblastoma: A Patterns-of-Care and Outcomes Analysis of the National Cancer Database"],"prefix":"10.1227","volume":"83","author":[{"given":"Andrew","family":"Orton","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin","family":"Boothe","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Evans","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Univeristy of Utah School of Medicine and Health Sciences, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Lloyd","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus M","family":"Monroe","sequence":"additional","affiliation":[{"name":"Department of Head and Neck Surgery, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis C","family":"Shrieve","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying J","family":"Hitchcock","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Utah, Salt Lake City, Utah"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2018,11]]},"reference":[{"issue":"8","key":"bib1-20231011","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1288\/00005537-199208000-00001","article-title":"Esthesioneuroblastoma: the UCLA experience 1970-1990","volume":"102","author":"Dulguerov","year":"1992","journal-title":"Laryngoscope"},{"issue":"9","key":"bib2-20231011","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1034\/j.1600-0463.2002.1100907.x","article-title":"Esthesioneuroblastoma: a Danish clinicopathological study of 40 consecutive cases","volume":"110","author":"Ingeholm","year":"2002","journal-title":"APMIS"},{"issue":"1","key":"bib3-20231011","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12105-014-0547-3","article-title":"Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes","volume":"9","author":"Bell","year":"2015","journal-title":"Head Neck Pathol"},{"issue":"3","key":"bib4-20231011","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/1097-0142(197603)37:3<1571::AID-CNCR2820370347>3.0.CO;2-L","article-title":"Olfactory neuroblastoma. A clinical analysis of 17 cases","volume":"37","author":"Kadish","year":"1976","journal-title":"Cancer"},{"issue":"5","key":"bib5-20231011","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1227\/00006123-199305000-00002","article-title":"Esthesioneuroblastoma","volume":"32","author":"Morita","year":"1993","journal-title":"Neurosurgery"},{"issue":"1","key":"bib6-20231011","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11912-014-0423-z","article-title":"Prognosis and biology in esthesioneuroblastoma: the emerging role of Hyams grading system","volume":"17","author":"Saade","year":"2015","journal-title":"Curr Oncol Rep"},{"issue":"7","key":"bib7-20231011","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/lary.25862","article-title":"Patterns of regional and distant metastasis in esthesioneuroblastoma","volume":"126","author":"Banuchi","year":"2016","journal-title":"Laryngoscope"},{"issue":"4","key":"bib8-20231011","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0360-3016(93)90457-7","article-title":"Esthesioneuroblastoma: the role of adjuvant radiation therapy","volume":"27","author":"Foote","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"bib9-20231011","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/1097-0142(197909)44:3<1087::AID-CNCR2820440343>3.0.CO;2-A","article-title":"Esthesioneuroblastoma","volume":"44","author":"Elkon","year":"1979","journal-title":"Cancer"},{"issue":"3","key":"bib10-20231011","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/00016480310001295","article-title":"Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000","volume":"123","author":"Theilgaard","year":"2003","journal-title":"Acta Otolaryngol"},{"issue":"2","key":"bib11-20231011","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0360-3016(02)02941-3","article-title":"Esthesioneuroblastoma: irradiation alone and surgery alone are not enough","volume":"54","author":"Gruber","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"8","key":"bib12-20231011","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.oraloncology.2013.04.013","article-title":"Multimodal treatment and long-term outcome of patients with esthesioneuroblastoma","volume":"49","author":"Modesto","year":"2013","journal-title":"Oral Oncol"},{"issue":"7","key":"bib13-20231011","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/jso.23568","article-title":"Comparing national cancer registries: The National Cancer Data Base (NCDB) and the Surveillance, Epidemiology, and End Results (SEER) program","volume":"109","author":"Mohanty","year":"2014","journal-title":"J Surg Oncol."},{"key":"bib14-20231011","article-title":"Data Dictionary PUF 2015","author":"National Cancer Database.","journal-title":"Surgical Procedure of the Primary Site."},{"issue":"4","key":"bib15-20231011","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2307\/3001616","article-title":"Some methods for strengthening the common? 2 tests","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics."},{"issue":"3","key":"bib16-20231011","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2105\/AJPH.79.3.340","article-title":"Modeling and variable selection in epidemiologic analysis.","volume":"79","author":"Greenland","year":"1989","journal-title":"Am J Public Health"},{"issue":"26","key":"bib17-20231011","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1002\/sim.7048","article-title":"Multiple imputation of missing covariates for the Cox proportional hazards cure model","volume":"35","author":"Beesley","year":"2016","journal-title":"Stat Med"},{"issue":"1","key":"bib18-20231011","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1186\/1471-2288-9-57","article-title":"Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines","volume":"9","author":"Marshall","year":"2009","journal-title":"BMC Med Res Methodol"},{"issue":"15","key":"bib19-20231011","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/sim.3618","article-title":"Imputing missing covariate values for the Cox model","volume":"28","author":"White","year":"2009","journal-title":"Stat Med."},{"issue":"11","key":"bib20-20231011","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1093\/brain\/awr061","article-title":"Multiple imputation models should incorporate the outcome in the model of interest","volume":"134","author":"Bartlett","year":"2011","journal-title":"Brain"},{"issue":"1","key":"bib21-20231011","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1748-717X-6-41","article-title":"Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database","volume":"6","author":"Platek","year":"2011","journal-title":"Radiat Oncol"},{"issue":"11","key":"bib22-20231011","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1017\/S0022215100135649","article-title":"Olfactory neural tumours the role of external beam radiotherapy","volume":"110","author":"Slevin","year":"1996","journal-title":"J Laryngol Otol."},{"issue":"12","key":"bib23-20231011","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/hed.20920","article-title":"Esthesioneuroblastoma: the Princess Margaret Hospital experience","volume":"30","author":"Bachar","year":"2008","journal-title":"Head Neck"},{"issue":"1","key":"bib24-20231011","first-page":"1","article-title":"Outcome and analysis of the surgical management of esthesioneuroblastoma","volume":"26","author":"Irish","year":"1997","journal-title":"J Otolaryngol"},{"issue":"4","key":"bib25-20231011","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.ijrobp.2009.09.019","article-title":"Outcome and prognostic factors in olfactory neuroblastoma: a rare cancer network study","volume":"78","author":"Ozsahin","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"bib26-20231011","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/hed.20127","article-title":"Olfactory neuroblastoma: the 22-year experience at one comprehensive cancer center","volume":"27","author":"Diaz","year":"2005","journal-title":"Head Neck"},{"issue":"2","key":"bib27-20231011","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s11060-008-9645-y","article-title":"Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma","volume":"90","author":"Porter","year":"2008","journal-title":"J Neurooncol"},{"issue":"2","key":"bib28-20231011","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.radonc.2015.10.002","article-title":"Spread patterns of lymph nodes and the value of elective neck irradiation for esthesioneuroblastoma","volume":"117","author":"Yin","year":"2015","journal-title":"Radiother Oncol"},{"issue":"3","key":"bib29-20231011","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/jjco\/hyi245","article-title":"Treatment outcomes of patients with AJCC stage IVC nasopharyngeal carcinoma: benefits of primary radiotherapy","volume":"36","author":"Yeh","year":"2006","journal-title":"Jpn J Clin Oncol"},{"issue":"3","key":"bib30-20231011","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0360-3016(88)90298-2","article-title":"Esthesioneuroblastoma: a comparison of two treatment eras","volume":"15","author":"Spaulding","year":"1988","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"bib31-20231011","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/00000421-198906000-00008","article-title":"High-dose chemotherapy and autologous marrow transplantation for esthesioneuroblastoma and sinonasal undifferentiated carcinoma","volume":"12","author":"Stewart","year":"1989","journal-title":"Am J Clin Oncol"},{"issue":"5","key":"bib32-20231011","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00006123-199805000-00040","article-title":"Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience","volume":"42","author":"Mcelroy","year":"1998","journal-title":"Neurosurgery"},{"issue":"2","key":"bib33-20231011","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1200\/JCO.2009.23.9194","article-title":"Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes","volume":"28","author":"Gunderson","year":"2010","journal-title":"J Clin Oncol"},{"issue":"31","key":"bib34-20231011","doi-asserted-by":"crossref","first-page":"8065","DOI":"10.1200\/JCO.2005.02.4976","article-title":"A population-based validation of the American Joint Committee on Cancer melanoma staging system","volume":"23","author":"Gimotty","year":"2005","journal-title":"J Clin Oncol"},{"issue":"6","key":"bib35-20231011","doi-asserted-by":"crossref","first-page":"e2711","DOI":"10.1097\/MD.0000000000002711","article-title":"TNM staging of colorectal cancer should be reconsidered according to weighting of the T stage","volume":"95","author":"Li","year":"2016","journal-title":"Medicine"},{"issue":"30","key":"bib36-20231011","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1200\/JCO.2013.51.1477","article-title":"Revised staging classification improves outcome prediction for small intestinal neuroendocrine tumors","volume":"31","author":"Kim","year":"2013","journal-title":"J Clin Oncol"}],"container-title":["Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neurosurgery\/article-pdf\/83\/5\/940\/32601168\/nyx535.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ovid.com\/00006123-201811000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:45:46Z","timestamp":1786121146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006123-201811000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,22]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1093\/neuros\/nyx535","relation":{},"ISSN":["0148-396X","1524-4040"],"issn-type":[{"value":"0148-396X","type":"print"},{"value":"1524-4040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,22]]}}}